Nininger Medical Inc.
Nininger Medical is dedicated to creating life-saving technology and therapies to treat the millions of patients suffering from structural heart failure. Founded in 2019, the company focuses on advancing transcatheter heart valve therapies and has received an SBIR grant from the National Science Foundation to develop ground-breaking technology.
Industries
medical-device
Nr. of Employees
small (1-50)
Nininger Medical Inc.
Patents
Products
Transcatheter heart valve therapy development program
An ongoing development program to create transcatheter valve-based therapies for patients with structural heart disease.
Transcatheter heart valve therapy development program
An ongoing development program to create transcatheter valve-based therapies for patients with structural heart disease.
Services
R&D program focused on creating technologies to treat structural heart failure via transcatheter approaches.
R&D program focused on creating technologies to treat structural heart failure via transcatheter approaches.
Expertise Areas
- Transcatheter heart valve development
- Structural heart disease therapies
- Cardiovascular device R&D
- Grant-funded biomedical research
Key Technologies
- Transcatheter heart valve technologies
- Minimally invasive cardiovascular device methods
News & Updates
In December 2020, Nininger Medical received an SBIR grant from the National Science Foundation to develop ground-breaking technology.
In December 2020, Nininger Medical received an SBIR grant from the National Science Foundation to develop ground-breaking technology.